Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405

Open Access

Peer-reviewed

Research Article

Brandon L. Probst,

Affiliation Department of Research, Reata Pharmaceuticals Inc., Irving, Texas, United States of America
⨯
Lyndsey McCauley,

Affiliation Department of Research, Reata Pharmaceuticals Inc., Irving, Texas, United States of America
⨯
Isaac Trevino,

Affiliation Department of Research, Reata Pharmaceuticals Inc., Irving, Texas, United States of America
⨯
W. Christian Wigley,

Affiliation Department of Research, Reata Pharmaceuticals Inc., Irving, Texas, United States of America
⨯
Deborah A. Ferguson

* E-mail: deborah.ferguson@reatapharma.com

Affiliation Department of Research, Reata Pharmaceuticals Inc., Irving, Texas, United States of America
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Glutathione
Is the Subject Area "Glutathione" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Sex ratio
Is the Subject Area "Sex ratio" applicable to this article?

Thanks for your feedback.